Experimentally promising antischistosomal drugs: A review of some drug candidates not reaching the clinical use

Parasitology Research

Volumn 105, Issue 4, 2009, Pages 899-906

  Abdul Ghani, Rashad A ^a,b   Loutfy, Naguiba ^b   Hassan, Azza ^b  

^a SANA A UNIVERSITY   (Yemen)

^b High Institute of Public Health Egypt   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

10 [2 (DIETHYLAMINO)ETHYL] 9(10H) ACRIDINONE (2 THIAZOLIDINYLIDENE)HYDRAZONE; ANTIMALARIAL AGENT; ANTISCHISTOSOMAL AGENT; ARTEMISININ DERIVATIVE; BENZODIAZEPINE; CYSTEINE PROTEINASE INHIBITOR; CYTOCHALASIN D; DIAZEPAM; ENDOPEROXIDE; FLUNITRAZEPAM; FURAZOLIDONE; HYCANTHONE; K 11777; MECLONAZEPAM; NIRIDAZOLE; OXADIAZOLE DERIVATIVE; OXAMNIQUINE; OZ 209; OZ 277; OZ 288; PRAZIQUANTEL; REACTIVE OXYGEN METABOLITE; TRIOXOLANE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CHAGAS DISEASE; CHEMOTHERAPY; CYTOTOXICITY; DISEASE CONTROL; DOSE RESPONSE; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; ECHINOSTOMIASIS; FASCIOLIASIS; IC 50; MUSCLE CONTRACTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMIASIS MANSONI; SCHISTOSOMULUM;

ANIMALS; HUMANS; SCHISTOSOMA; SCHISTOSOMIASIS; SCHISTOSOMICIDES;

EID: 69249208531     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-009-1546-2     Document Type: Review

References (58)

1. MH Abdulla KC Lim M Sajid JH McKerrow CR Caffrey 2007 Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor PLoS Med 4 e14
2. HM Alger DL Williams 2002 The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase Mol Biochem Parasitol 121 129 139
3. JL Ambroso C Harris 1994 In vitro embryotoxicity of the cysteine proteinase inhibitors benzyloxycarbonyl-phenylalanine-alanine-diazomethane (Z-Phe-Ala-CHN2) and benzyloxycarbonyl-phenylalanine-phenylalanine-diazomethane (Z-Phe-Phe-CHN2) Teratology 50 214 228
4. M Ansseau A Doumont D Thiry R von Frenckell J Collard 1985 Initial study of methylclonazepam in generalized anxiety disorder. Evidence for greater power in the cross-over design Psychoparmacology 87 130 135
5. AP Baard DK Sommers PJ Honiball ED Fourie LE du Toit 1979 Preliminary results in human schistosomiasis with Ro 11-3128 S Afr Med J 55 617 618
6. JL Bennett 1980 Characteristics of antischistosomal benzodiazepine binding sites in Schistosoma mansoni J Parasitol 66 742 747
7. NR Bergquist DG Colley 1998 Schistosomiasis vaccine: research to development Parasitol Today 14 99 104
8. R Bergquist M Al-Sherbiny R Barakat R Olds 2002 Blueprint for schistosomiasis vaccine development Acta Trop 82 183 192
9. QD Bickle M Sacko DA Vignali 1990 Induction of immunity against Schistosoma mansoni by drug (Ro11-3128)-terminated infections: analysis of surface antigen recognition Parasite Immunol 12 569 586
10. SS Botros JL Bennett 2007 Praziquantel resistance Expert Opin Drug Discov 2 S35 S40
11. CS Bricker JW Depenbusch JL Bennett DP Thompson 1983 The relationship between tegumental disruption and muscle contraction in Schistosoma mansoni exposed to various compounds Z Parasitenkd 69 61 71
12. CR Caffrey 2007 Chemotherapy of schistosomiasis: present and future Curr Opin Chem Biol 11 433 439
13. CR Caffrey JH McKerrow JP Salter M Sajid 2004 Blood 'n' guts: an update on schistosome digestive peptidases Trends Parasitol 20 241 248
14. A Capron 1998 Schistosomiasis: forty years' war on the worm Parasitol Today 14 379 384
15. Cioli D (2005) Research towards new treatments for schistosomiasis. Report of the Scientific Working Group on Schistosomiasis, TDR/SWG/07, 70-75. http://www.who.int/tdr
16. D Cioli C Valle F Angelucci AE Miele 2008 Will new antischistosomal drugs finally emerge? Trends Parasitol 24 379 382
17. PM Coelho LH Pereira RT de Mello 1995 Antischistosomal activity of acridanone-hydrazones in Cebus monkeys experimentally infected with the SJ strain of Schistosoma mansoni Rev Soc Bras Med Trop 28 179 183
18. TH Eichhold EB Hookfin YO Taiwo B De KR Wehmeyer 1997 Isolation and quantification of fluoroacetate in rat tissues, following dosing of Z-Phe-Ala-CH2-F, a peptidyl fluoromethyl ketone protease inhibitor J Pharm Biomed Anal 16 459 467
19. F Eshete JL Bennett 1990 Schistosoma mansoni: biochemical characteristics of the antischistosomal effects of Ro 15-5458 Exp Parasitol 71 69 80
20. F Eshete JL Bennett 1991 The schistosomicidal compound Ro 15-5458 causes a reduction in the RNA content of Schistosoma mansoni Mol Biochem Parasitol 45 1 8
21. A Fenwick JB Webster 2006 Schistosomiasis: challenges for control, treatment and drug resistance Curr Opin Infect Dis 19 577 582 (Pubitemid 44665464)
22. S Gromer S Urig K Becker 2004 The thioredoxin system-from science to clinic Med Res Rev 24 40 89
23. B Gryseels K Polman J Clerinx L Kestens 2006 Human schistosomiasis Lancet 368 1106 1118
24. FR Guirguis 2003 Efficacy of praziquantel and Ro 15-5458, a 9-acridanone-hydrazone derivative, against Schistosoma haematobium Arzneimittelforschung 53 57 61
25. P Hagan O Sharaf 2003 Schistosomiasis vaccines Expert Opin Biol Ther 3 1271 1278
26. W Hunkeler H Möhler L Pieri P Polc EP Bonetti R Cumin R Schaffner W Haefely 1981 Selective antagonists of benzodiazepines Nature 290 514 516
27. G Kamel A Metwally F Guirguis NG Nessim M Noseir 2000 Effect of a combination of the new antischistosomal drug Ro 15-5458 and praziquantel on different strains of Schistosoma mansoni infected mice Arzneimittelforschung 50 391 394
28. N Katz 1999 Schistosomiasis vaccines: the need for more research before clinical trials Parasitol Today 15 165 167
29. J Keiser J Utzinger M Tanner Y Dong JL Vennerstrom 2006 The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica J Antimicrob Chemother 58 1193 1197
30. CH King K Dickman DJ Tisch 2005 Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis Lancet 365 1561 1569
31. RL Krauth-Siegel H Bauer RH Schirmer 2005 Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia Angew Chem Int Ed Engl 44 690 715
32. AN Kuntz E Davioud-Charvet AA Sayed LL Califf J Dessolin ES Arnér DL Williams 2007 Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target PLoS Med 4 e206
33. A Mahajan V Kumar NR Mansour Q Bickle K Chibale 2008 Meclonazepam analogues as potential new antihelmintic agents Bioorg Med Chem Lett 18 2333 2336
34. AJ Mastin RA Wilson QD Bickle 1985 Induction of resistance to Schistosoma mansoni in mice by chemotherapy: migration of schistosomula in primary and challenge infections Parasitology 90 519 528
35. JH McKerrow JC Engel CR Caffrey 1999 Cysteine protease inhibitors as chemotherapy for parasitic infections Bioorg Med Chem 7 639 644
36. A Metwally A Abdel Hadi EG Mikhail O Aboú Shadi H Sabry H el-Nahal 1997 Study of the efficacy of the new antischistosomal drug 10-[2-(diethylamino)ethyl]-9-acridanone-(thiazolidin-2-ylidene) hydrazone against an Egyptian strain of Schistosoma mansoni in mice Arzneimittelforschung 47 975 979
37. F Noël DL Mendonça-Silva JP Thibaut DV Lopes 2007 Characterization of two classes of benzodiazepine binding sites in Schistosoma mansoni Parasitology 134 1003 1012
38. R Pax JL Bennett R Fetterer 1978 A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum Naunyn Schmiedebergs Arch Pharmacol 304 309 315
39. LH Pereira PM Coelho JO Costa RT de Mello 1995 Activity of 9-acridanone-hydrazone drugs detected at the pre-postural phase, in the experimental schistosomiasis mansoni Mem Inst Oswaldo Cruz 90 425 428
40. L Pica-Mattoccia LCD Dias R Moroni D Cioli 1993 Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/ oxamniquine-resistant strains are mutated in the same gene Exp Parasitol 77 445 449
41. L Pica-Mattoccia A Ruppel CM Xia D Cioli 2008 Praziquantel and the benzodiazepine Ro 11-3128 do not compete for the same binding sites in schistosomes Parasitology 135 47 54
42. S Rollas SG Küçükgüzel 2007 Biological activities of hydrazone derivatives Molecules 12 1910 1939
43. AA Sabah C Fletcher G Webbe MJ Doenhoff 1986 Schistosoma mansoni: chemotherapy of infections of different ages Exp Parasitol 61 294 303
44. AA Sayed A Simeonov CJ Thomas J Inglese CP Austin DL Williams 2008 Identification of oxadiazoles as new drug leads for the control of schistosomiasis Nat Med 14 407 412
45. A Simeonov A Jadhav AA Sayed Y Wang ME Nelson CJ Thomas J Inglese DL Williams CP Austin 2008 Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade PLoS Negl Trop Dis 2 e127
46. DA Smith QD Bickle PM Kaye 1994 Resistance induced by drug abbreviated Schistosoma mansoni infections: treatment with the drug Ro11-3128 leads to enhanced antigen presentation Immunology 82 419 426
47. P Steinmann J Keiser R Bos M Tanner J Utzinger 2006 Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk Lancet Infect Dis 6 411 425
48. Stohler HR (1978) Ro 11-3128, a novel schistosomicidal compound. In: Siegenthaler, W. and Lüthy, R. (Eds) Current Chemotherapy, Proceedings of the 10th Congress of Chemotherapy Vol. 1. American Society for Microbiology, Washington, pp. 147
49. Stohler HR, Montavon M (1984) 9-Acridanone-hydrazones, a novel class of broad-spectrum schistosomicidal agents. In: Xl International Congress for Tropical Medicine and Malaria, Calgary, Canada, 16-22 September, p. 148, University of Calgary, Calgary
50. RF Sturrock J Bain G Webbe MJ Doenhoff H Stohler 1987 Parasitological evaluation of curative and subcurative doses of 9-acridanonehydrazone drugs against Schistosoma mansoni in baboons, and observations on changes in serum levels of anti-egg antibodies detected by ELISA Trans R Soc Trop Med Hyg 81 188 192
51. SM Sulaiman HM Ali MM Homeida JL Bennett 1989 Efficacy of a new Hoffmann-La Roche compound (Ro 15-5458) against Schistosoma mansoni (Gezira strain, Sudan) in vervet monkeys (Cercopithecus aethiops) Trop Med Parasitol 40 335 336
52. JP Thibaut LM Monteiro LC Leite CM Menezes LM Lima F Noël 2009 The effects of 3-methylclonazepam on Schistosoma mansoni musculature are not mediated by benzodiazepine receptors Eur J Pharmacol 606 9 16
53. J Utzinger S Xiao EK N'Goran R Bergquist M Tanner 2003 The potential of artemether for the control of schistosomiasis Int J Parasitol 31 1549 1562
54. JL Vennerstrom S Arbe-Barnes R Brun SA Charman FC Chiu J Chollet Y Dong A Dorn D Hunziker H Matile K McIntosh M Padmanilayam J Santo Tomas C Scheurer B Scorneaux Y Tang H Urwyler S Wittlin WN Charman 2004 Identification of an antimalarial synthetic trioxolane drug development candidate Nature 430 900 904
55. MM Wasilewski KC Lim J Phillips JH McKerrow 1996 Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo Mol Biochem Parasitol 81 179 189
56. WHO Expert Committee (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis. WHO Tech Rep Ser 912: i-vi, 1-57
57. PJ Wood TE Mansour 1986 Schistosoma mansoni: serotonin uptake and its drug inhibition Exp Parasitol 62 114 119
58. SH Xiao J Keiser J Chollet J Utzinger Y Dong Y Endriss JL Vennerstrom M Tanner 2007 In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species Antimicrob Agents Chemother 51 1440 1445